Diasorin Liaison testing services
ID: 25AP2581Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF244-NETWORK CONTRACT OFFICE 4 (36C244)PITTSBURGH, PA, 15215, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

CHEMICAL ANALYSIS INSTRUMENTS (6630)

Original Source

https://sam.gov/opp/8fcf0a2bb94f4d599db9e0eea0398154/view
Timeline
    Description

    The Department of Veterans Affairs, specifically the VISN 4 Network Contracting Office, intends to award a sole source contract for Diasorin Liaison testing services at the Philadelphia VA Medical Center in Pennsylvania. This procurement aims to secure essential testing services from Diasorin, which is deemed the only responsible source capable of fulfilling the agency's requirements, with the contract period set from May 17, 2025, to May 16, 2026. The services are critical for the department's operations, ensuring accurate and reliable laboratory testing for veterans. Interested parties who believe they can meet these requirements are encouraged to submit supporting evidence to the Contracting Officer, Roger Tang, at roger.tang@va.gov, by April 10, 2025, at 10:00 AM EST.

    Point(s) of Contact
    Roger Tang
    2158235800203243
    roger.tang@va.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Diasorin Liaison testing services
    Currently viewing
    Special Notice
    Similar Opportunities
    Q301 Reference Laboratory Testing for VA Portland Health Care System
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide Referral Laboratory services for histocompatibility and immunogenetics testing to support the VA Portland Health Care System's transplant program. The selected laboratory must be accredited by the Organ Procurement and Transplantation Network (OPTN) and capable of performing a range of specialized tests, including HLA typing and antibody screening, while adhering to strict regulatory standards and providing 24/7 critical testing services. This contract, which spans from April 1, 2026, to March 31, 2031, is crucial as the VA Portland Health Care System currently lacks the capability to perform these tests in-house. Interested parties must submit their responses by December 26, 2025, to Eric Lingenfelter at eric.lingenfelter@va.gov, with no funding amount specified at this stage.
    6506--SSJ posting - Notice of Intent to Sole Source
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the VA Pittsburgh Healthcare System (VAPHS), intends to negotiate a sole source contract with Vitalant for the procurement of blood products over a three-year period. This contract, classified under NAICS code 621991, will utilize simplified acquisition procedures and is justified under FAR Part 12 and FAR 13.5 due to Vitalant being the only responsible source capable of meeting the urgent needs for emergency issue platelets and facilitating a blood transfer program with local hospitals. The anticipated contract will be a firm-priced, indefinite-delivery, indefinite-quantity agreement, with the contracting officer determining that the expected costs will be fair and reasonable. For further inquiries, interested parties may contact Contracting Officer Victoria Droz at Victoria.Droz@va.gov or by phone at 814-515-4454.
    Distribution of Biorad Bioplex Reagents and Consumables for Laboratory Tests.
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 20, is seeking a qualified contractor for a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract focused on the distribution of BioRad BioPlex reagents and consumables for laboratory tests at the Seattle VA Medical Center. The contractor will be responsible for supplying FDA-approved equipment, reagents, controls, calibrators, and all necessary consumables, along with installation, validation, technical support, preventative maintenance, and staff training, ensuring compliance with specific performance requirements such as rapid analysis and automated calibration. This procurement is critical for enhancing patient care through immunoassays that diagnose various health conditions, including infectious diseases and autoimmune disorders. Quotes are due by December 19, 2025, at 17:00 Pacific Time, and interested parties can contact Hector Gonzalez at hector.gonzalez1@va.gov or by phone at 360-553-7632 for further information.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to the diagnosis, prevention, or treatment of diseases. The procurement aims to establish contracts for domestic delivery of medical laboratory services, ensuring compliance with all relevant state, federal, and local regulations, including necessary licenses and permits for testing services. This opportunity is critical for enhancing patient care through accurate diagnostic testing, with the expectation that offerors will provide new items only, adhering to FDA regulatory requirements. Interested vendors can contact the FSS Help Desk at Fss.Help@va.gov or call 708-786-7737 for further details, as the solicitation is currently pending and specific deadlines for proposal submissions will be outlined in the official solicitation documents.
    Q301--Specialized Genetic Testing and Consultation Services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, Network Contracting Office 17, is seeking sources for specialized genetic testing and consultation services to support the South Texas Veterans Health Care System. The procurement aims to provide comprehensive genetic laboratory testing services for patient specimens that cannot be processed on-site, including specific cancer-related tests and complementary studies to reduce variants of unknown significance (VUS). These services are critical for accurate diagnosis and treatment of health conditions among veterans, ensuring compliance with established medical standards and regulations. Interested parties must submit their responses by December 30, 2025, including company information, SAM Unique Entity Identification (UEI), business size, socio-economic status, and a capability statement addressing all requirements outlined in the Statement of Work. For further inquiries, contact Kathryn Prose at kathryn.prose@va.gov or (254) 217-2835.
    Distribution of CPRR Immunoassays for BioRad BioPlex Lab Tests.
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide the distribution of BioRad BioPlex laboratory reagents for the Seattle VA Medical Center. The procurement aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for automated immunoassay instrumentation capable of performing a variety of diagnostic tests, including those for autoimmune diseases and infectious agents. These reagents and instruments are critical for enhancing laboratory capabilities in diagnosing and managing patient care within the VA system. Interested small businesses must submit their quotes by December 19, 2025, at 17:00 Pacific Time, and can direct inquiries to Hector Gonzalez at hector.gonzalez1@va.gov or by phone at 360-553-7632.
    To Correct Description
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking responses to a Special Notice regarding a procurement opportunity related to medical laboratory testing services. Respondents are required to complete specific columns in the attached test list, particularly Columns D and E, which pertain to in-house testing capabilities and third-party courier services. This opportunity is crucial for ensuring the availability and accuracy of medical laboratory tests, which play a vital role in patient care and treatment decisions. Interested parties should reach out to Eric A. Lingenfelter at Eric.Lingenfelter@va.gov or call 360-852-9891 for further details and to obtain the necessary documents for submission.
    To Correct Description
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking responses to a Special Notice regarding a procurement opportunity related to medical laboratory testing services. Respondents are required to complete specific columns in the attached test list, particularly Columns D and E, which pertain to in-house testing capabilities and third-party courier services. This opportunity is crucial for ensuring the efficient provision of medical laboratory services, which play a vital role in supporting the healthcare needs of veterans. Interested parties should reach out to Eric A. Lingenfelter at Eric.Lingenfelter@va.gov or call 360-852-9891 for further details and to obtain the necessary documents for submission.
    Emergent Reference Lab Testing
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking contractors to provide Emergent Reference Lab Testing services for the Charleston VA Healthcare System. The procurement involves a range of specialized laboratory tests, as detailed in the Statement of Work and Price Schedule, with specific exemptions to the 24-hour turnaround time requirement for certain complex tests. This opportunity is critical for ensuring timely and accurate medical laboratory testing, which supports the healthcare needs of veterans. Interested parties must submit their offers by December 19, 2025, at 10 AM ET, and can direct inquiries to Monica Reed at monica.reed@va.gov or by phone at 334-450-5679.
    Q301--RNA Extraction and Sequencing - DURHAM VA
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking a sole-source, firm-fixed-price contract with Duke University for RNA extraction and sequencing services. This procurement supports the VA's ongoing research on COVID-19 epidemiology, immunology, and clinical characteristics, which involves processing 800 whole blood RNA sequencing samples and performing 1600 RNA extractions. The total contract value is $251,672.80, with a performance period running from April 1, 2023, to March 31, 2024. Interested parties can reach out to Contracting Officer Ann Marie Stewart at annmarie.stewart@va.gov or by phone at 401-919-0878 for further details.